Rightway · 2 months ago
Analyst, Rebate Analytics
Rightway is on a mission to harmonize healthcare for everyone, everywhere. The Analyst, Rebate Analytics will perform analytics on pharmacy claims data, interpret rebate trends, and evaluate client-level rebate performance to support strategic decision-making.
Health CareMedical
Responsibilities
Analyze pharmacy claims data to identify trends, cost drivers, and opportunities for savings or program improvement
Generate standard and ad-hoc reports for internal teams, clients, and external partners
Analyze pharmacy claims data to identify and interpret trends in manufacturer rebates and their impact on plan performance
Evaluate rebate guarantees and performance for clients, providing insights into drivers of variances and opportunities for optimization
Communicate rebate performance metrics to internal stakeholders and leadership
Collaborate with Account Management and Client Services to address client inquiries and support business reviews
Contribute to rebate audit support and internal control documentation as needed
Qualification
Required
Bachelor's degree or proven industry experience will be acceptable in lieu of degree
Minimum 1 to 3 years' relevant rebate or business experience, preferably with a PBM
Financial and reporting knowledge experience is a plus
Effective verbal and written communication skills
A decisive individual who possesses a detail-oriented perspective
Ability to work with peers in a team effort
Demonstrated ability to manage multiple priorities and deadlines
Capability to efficiently complete tasks in a fast-paced environment
Preferred
A knowledgeable individual with appropriate industry experience, preferably in the healthcare or PBM industry
Proficient in Microsoft Office and industry related software programs
Company
Rightway
Rightway is a health technology company that is simplifying the healthcare experience for clients and members.
Funding
Current Stage
Late StageTotal Funding
$238.75MKey Investors
Khosla VenturesThrive CapitalTiger Global Management
2024-03-29Series Unknown· $108.75M
2021-03-30Series C· $100M
2019-11-21Series B· $20M
Recent News
2025-12-11
2025-11-19
Company data provided by crunchbase